View Financial HealthThis company listing is no longer activeThis company may still be operating, however this listing is no longer active. Find out why through their latest events.See Latest EventsCemedine 配当と自社株買い配当金 基準チェック /56主要情報2.0%配当利回りn/aバイバック利回り総株主利回りn/a将来の配当利回りn/a配当成長2.5%次回配当支払日n/a配当落ち日n/a一株当たり配当金n/a配当性向15%最近の配当と自社株買いの更新Upcoming Dividend • Mar 23Upcoming dividend of JP¥5.00 per shareEligible shareholders must have bought the stock before 30 March 2022. Payment date: 17 June 2022. Payout ratio is a comfortable 13% and this is well supported by cash flows. Trailing yield: 1.2%. Lower than top quartile of Japanese dividend payers (3.4%). Lower than average of industry peers (2.6%).Upcoming Dividend • Sep 22Upcoming dividend of JP¥5.00 per shareEligible shareholders must have bought the stock before 29 September 2021. Payment date: 02 December 2021. Trailing yield: 1.2%. Lower than top quartile of Japanese dividend payers (3.0%). Lower than average of industry peers (1.9%).Upcoming Dividend • Mar 23Upcoming dividend of JP¥5.00 per shareEligible shareholders must have bought the stock before 30 March 2021. Payment date: 18 June 2021. Trailing yield: 1.3%. Lower than top quartile of Japanese dividend payers (2.7%). Lower than average of industry peers (1.8%).すべての更新を表示Recent updatesお知らせ • Jul 21Cemedine to Be Delisted from the Standard Section of Tokyo Stock ExchangeCemedine Co., Ltd. will be delisted from the Standard section Of Tokyo Stock Exchange (TSE), effective July 28, 2022. The delisting is due to Becoming a wholly owned subsidiary of KANEKA CORPORATION.Reported Earnings • Jun 17Full year 2022 earnings released: EPS: JP¥98.59 (vs JP¥70.96 in FY 2021)Full year 2022 results: EPS: JP¥98.59 (up from JP¥70.96 in FY 2021). Revenue: JP¥28.6b (up 11% from FY 2021). Net income: JP¥1.48b (up 39% from FY 2021). Profit margin: 5.2% (up from 4.1% in FY 2021). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 24% per year but the company’s share price has only increased by 4% per year, which means it is significantly lagging earnings growth.Reported Earnings • May 15Full year 2022 earnings released: EPS: JP¥98.59 (vs JP¥70.96 in FY 2021)Full year 2022 results: EPS: JP¥98.59 (up from JP¥70.96 in FY 2021). Revenue: JP¥28.6b (up 11% from FY 2021). Net income: JP¥1.48b (up 39% from FY 2021). Profit margin: 5.2% (up from 4.1% in FY 2021). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 24% per year but the company’s share price has only increased by 7% per year, which means it is significantly lagging earnings growth.お知らせ • May 14Cemedine Co., Ltd., Annual General Meeting, Jun 15, 2022Cemedine Co., Ltd., Annual General Meeting, Jun 15, 2022.Board Change • Apr 27Less than half of directors are independentFollowing the recent departure of a director, there are only 2 independent directors on the board. The company's board is composed of: 2 independent directors. 6 non-independent directors. Independent External Director Takao Oikawa was the last independent director to join the board, commencing their role in 2015. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.お知らせ • Apr 08Cemedine Co., Ltd. to Report Fiscal Year 2022 Results on May 12, 2022Cemedine Co., Ltd. announced that they will report fiscal year 2022 results on May 12, 2022Upcoming Dividend • Mar 23Upcoming dividend of JP¥5.00 per shareEligible shareholders must have bought the stock before 30 March 2022. Payment date: 17 June 2022. Payout ratio is a comfortable 13% and this is well supported by cash flows. Trailing yield: 1.2%. Lower than top quartile of Japanese dividend payers (3.4%). Lower than average of industry peers (2.6%).Reported Earnings • Feb 09Third quarter 2022 earnings: Revenues and EPS in line with analyst expectationsThird quarter 2022 results: EPS: JP¥30.45 (up from JP¥26.24 in 3Q 2021). Revenue: JP¥7.35b (up 6.5% from 3Q 2021). Net income: JP¥457.0m (up 16% from 3Q 2021). Profit margin: 6.2% (up from 5.7% in 3Q 2021). The increase in margin was driven by higher revenue. Revenue was in line with analyst estimates. Over the last 3 years on average, earnings per share has increased by 21% per year but the company’s share price has only increased by 1% per year, which means it is significantly lagging earnings growth.Reported Earnings • Nov 10Second quarter 2022 earnings released: EPS JP¥28.25 (vs JP¥10.75 in 2Q 2021)The company reported a strong second quarter result with improved earnings, revenues and profit margins. Second quarter 2022 results: Revenue: JP¥7.06b (up 13% from 2Q 2021). Net income: JP¥424.0m (up 163% from 2Q 2021). Profit margin: 6.0% (up from 2.6% in 2Q 2021). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 12% per year but the company’s share price has fallen by 3% per year, which means it is significantly lagging earnings.Upcoming Dividend • Sep 22Upcoming dividend of JP¥5.00 per shareEligible shareholders must have bought the stock before 29 September 2021. Payment date: 02 December 2021. Trailing yield: 1.2%. Lower than top quartile of Japanese dividend payers (3.0%). Lower than average of industry peers (1.9%).Reported Earnings • Aug 15First quarter 2022 earnings released: EPS JP¥24.09 (vs JP¥3.81 in 1Q 2021)The company reported a strong first quarter result with improved earnings, revenues and profit margins. First quarter 2022 results: Revenue: JP¥6.89b (up 22% from 1Q 2021). Net income: JP¥361.0m (up JP¥304.0m from 1Q 2021). Profit margin: 5.2% (up from 1.0% in 1Q 2021). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 5% per year but the company’s share price has fallen by 5% per year, which means it is significantly lagging earnings.Reported Earnings • Jun 19Full year 2021 earnings released: EPS JP¥70.96 (vs JP¥53.17 in FY 2020)The company reported a decent full year result with improved earnings and profit margins, although revenues were weaker. Full year 2021 results: Revenue: JP¥25.8b (down 6.9% from FY 2020). Net income: JP¥1.06b (up 34% from FY 2020). Profit margin: 4.1% (up from 2.9% in FY 2020). The increase in margin was driven by lower expenses. Over the last 3 years on average, earnings per share has increased by 1% per year but the company’s share price has fallen by 7% per year, which means it is significantly lagging earnings.Reported Earnings • May 16Full year 2021 earnings released: EPS JP¥70.96 (vs JP¥53.17 in FY 2020)The company reported a decent full year result with improved earnings and profit margins, although revenues were weaker. Full year 2021 results: Revenue: JP¥25.8b (down 6.9% from FY 2020). Net income: JP¥1.06b (up 34% from FY 2020). Profit margin: 4.1% (up from 2.9% in FY 2020). The increase in margin was driven by lower expenses. Over the last 3 years on average, earnings per share has increased by 1% per year but the company’s share price has fallen by 9% per year, which means it is significantly lagging earnings.Upcoming Dividend • Mar 23Upcoming dividend of JP¥5.00 per shareEligible shareholders must have bought the stock before 30 March 2021. Payment date: 18 June 2021. Trailing yield: 1.3%. Lower than top quartile of Japanese dividend payers (2.7%). Lower than average of industry peers (1.8%).Is New 90 Day High Low • Feb 15New 90-day high: JP¥747The company is up 6.0% from its price of JP¥704 on 17 November 2020. The Japanese market is up 11% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 11% over the same period.Reported Earnings • Feb 11Third quarter 2021 earnings released: EPS JP¥26.24 (vs JP¥17.89 in 3Q 2020)The company reported a decent third quarter result with improved earnings and profit margins, although revenues were weaker. Third quarter 2021 results: Revenue: JP¥6.91b (down 5.5% from 3Q 2020). Net income: JP¥393.0m (up 47% from 3Q 2020). Profit margin: 5.7% (up from 3.7% in 3Q 2020). The increase in margin was driven by lower expenses. Over the last 3 years on average, earnings per share has remained flat but the company’s share price has fallen by 8% per year, which means it is significantly lagging earnings.Is New 90 Day High Low • Jan 08New 90-day high: JP¥723The company is up 2.0% from its price of JP¥707 on 09 October 2020. The Japanese market is up 10.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 15% over the same period.お知らせ • Dec 04Cemedine Co., Ltd. to Report Q3, 2021 Results on Feb 09, 2021Cemedine Co., Ltd. announced that they will report Q3, 2021 results on Feb 09, 2021お知らせ • Oct 17Cemedine Co., Ltd. to Report Q2, 2021 Results on Nov 10, 2020Cemedine Co., Ltd. announced that they will report Q2, 2021 results on Nov 10, 2020お知らせ • Jul 17Cemedine Co., Ltd. to Report Q1, 2020 Results on Aug 07, 2020Cemedine Co., Ltd. announced that they will report Q1, 2020 results on Aug 07, 2020決済の安定と成長配当データの取得安定した配当: 4999の1株当たり配当金は過去10年間安定しています。増加する配当: 4999の配当金は過去10年間にわたって増加しています。配当利回り対市場Cemedine 配当利回り対市場4999 配当利回りは市場と比べてどうか？セグメント配当利回り会社 (4999)2.0%市場下位25% (JP)1.8%市場トップ25% (JP)3.8%業界平均 (Chemicals)2.3%アナリスト予想 (4999) (最長3年)n/a注目すべき配当: 4999の配当金 ( 1.98% ) はJP市場の配当金支払者の下位 25% ( 1.84% ) よりも高くなっています。高配当: 4999の配当金 ( 1.98% ) はJP市場の配当金支払者の上位 25% ( 3.79% ) と比較すると低いです。株主への利益配当収益カバレッジ: 4999は低い 配当性向 ( 15.2% ) であるため、配当金の支払いは利益によって十分にカバーされます。株主配当金キャッシュフローカバレッジ: 4999の 現金配当性向 ( 30.1% ) は比較的低く、配当金の支払いはキャッシュフローによって十分にカバーされています。高配当企業の発掘7D1Y7D1Y7D1YJP 市場の強力な配当支払い企業。View Management企業分析と財務データの現状データ最終更新日（UTC時間）企業分析2022/08/02 17:21終値2022/07/27 00:00収益2022/03/31年間収益2022/03/31データソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。分析モデルとスノーフレークこのレポートを生成するために使用した分析モデルの詳細は、当社のGitHubページでご覧いただけます。また、レポートの活用方法に関するガイドやYouTubeのチュートリアルも用意しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋Cemedine Co., Ltd. これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。0
Upcoming Dividend • Mar 23Upcoming dividend of JP¥5.00 per shareEligible shareholders must have bought the stock before 30 March 2022. Payment date: 17 June 2022. Payout ratio is a comfortable 13% and this is well supported by cash flows. Trailing yield: 1.2%. Lower than top quartile of Japanese dividend payers (3.4%). Lower than average of industry peers (2.6%).
Upcoming Dividend • Sep 22Upcoming dividend of JP¥5.00 per shareEligible shareholders must have bought the stock before 29 September 2021. Payment date: 02 December 2021. Trailing yield: 1.2%. Lower than top quartile of Japanese dividend payers (3.0%). Lower than average of industry peers (1.9%).
Upcoming Dividend • Mar 23Upcoming dividend of JP¥5.00 per shareEligible shareholders must have bought the stock before 30 March 2021. Payment date: 18 June 2021. Trailing yield: 1.3%. Lower than top quartile of Japanese dividend payers (2.7%). Lower than average of industry peers (1.8%).
お知らせ • Jul 21Cemedine to Be Delisted from the Standard Section of Tokyo Stock ExchangeCemedine Co., Ltd. will be delisted from the Standard section Of Tokyo Stock Exchange (TSE), effective July 28, 2022. The delisting is due to Becoming a wholly owned subsidiary of KANEKA CORPORATION.
Reported Earnings • Jun 17Full year 2022 earnings released: EPS: JP¥98.59 (vs JP¥70.96 in FY 2021)Full year 2022 results: EPS: JP¥98.59 (up from JP¥70.96 in FY 2021). Revenue: JP¥28.6b (up 11% from FY 2021). Net income: JP¥1.48b (up 39% from FY 2021). Profit margin: 5.2% (up from 4.1% in FY 2021). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 24% per year but the company’s share price has only increased by 4% per year, which means it is significantly lagging earnings growth.
Reported Earnings • May 15Full year 2022 earnings released: EPS: JP¥98.59 (vs JP¥70.96 in FY 2021)Full year 2022 results: EPS: JP¥98.59 (up from JP¥70.96 in FY 2021). Revenue: JP¥28.6b (up 11% from FY 2021). Net income: JP¥1.48b (up 39% from FY 2021). Profit margin: 5.2% (up from 4.1% in FY 2021). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 24% per year but the company’s share price has only increased by 7% per year, which means it is significantly lagging earnings growth.
お知らせ • May 14Cemedine Co., Ltd., Annual General Meeting, Jun 15, 2022Cemedine Co., Ltd., Annual General Meeting, Jun 15, 2022.
Board Change • Apr 27Less than half of directors are independentFollowing the recent departure of a director, there are only 2 independent directors on the board. The company's board is composed of: 2 independent directors. 6 non-independent directors. Independent External Director Takao Oikawa was the last independent director to join the board, commencing their role in 2015. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.
お知らせ • Apr 08Cemedine Co., Ltd. to Report Fiscal Year 2022 Results on May 12, 2022Cemedine Co., Ltd. announced that they will report fiscal year 2022 results on May 12, 2022
Upcoming Dividend • Mar 23Upcoming dividend of JP¥5.00 per shareEligible shareholders must have bought the stock before 30 March 2022. Payment date: 17 June 2022. Payout ratio is a comfortable 13% and this is well supported by cash flows. Trailing yield: 1.2%. Lower than top quartile of Japanese dividend payers (3.4%). Lower than average of industry peers (2.6%).
Reported Earnings • Feb 09Third quarter 2022 earnings: Revenues and EPS in line with analyst expectationsThird quarter 2022 results: EPS: JP¥30.45 (up from JP¥26.24 in 3Q 2021). Revenue: JP¥7.35b (up 6.5% from 3Q 2021). Net income: JP¥457.0m (up 16% from 3Q 2021). Profit margin: 6.2% (up from 5.7% in 3Q 2021). The increase in margin was driven by higher revenue. Revenue was in line with analyst estimates. Over the last 3 years on average, earnings per share has increased by 21% per year but the company’s share price has only increased by 1% per year, which means it is significantly lagging earnings growth.
Reported Earnings • Nov 10Second quarter 2022 earnings released: EPS JP¥28.25 (vs JP¥10.75 in 2Q 2021)The company reported a strong second quarter result with improved earnings, revenues and profit margins. Second quarter 2022 results: Revenue: JP¥7.06b (up 13% from 2Q 2021). Net income: JP¥424.0m (up 163% from 2Q 2021). Profit margin: 6.0% (up from 2.6% in 2Q 2021). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 12% per year but the company’s share price has fallen by 3% per year, which means it is significantly lagging earnings.
Upcoming Dividend • Sep 22Upcoming dividend of JP¥5.00 per shareEligible shareholders must have bought the stock before 29 September 2021. Payment date: 02 December 2021. Trailing yield: 1.2%. Lower than top quartile of Japanese dividend payers (3.0%). Lower than average of industry peers (1.9%).
Reported Earnings • Aug 15First quarter 2022 earnings released: EPS JP¥24.09 (vs JP¥3.81 in 1Q 2021)The company reported a strong first quarter result with improved earnings, revenues and profit margins. First quarter 2022 results: Revenue: JP¥6.89b (up 22% from 1Q 2021). Net income: JP¥361.0m (up JP¥304.0m from 1Q 2021). Profit margin: 5.2% (up from 1.0% in 1Q 2021). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 5% per year but the company’s share price has fallen by 5% per year, which means it is significantly lagging earnings.
Reported Earnings • Jun 19Full year 2021 earnings released: EPS JP¥70.96 (vs JP¥53.17 in FY 2020)The company reported a decent full year result with improved earnings and profit margins, although revenues were weaker. Full year 2021 results: Revenue: JP¥25.8b (down 6.9% from FY 2020). Net income: JP¥1.06b (up 34% from FY 2020). Profit margin: 4.1% (up from 2.9% in FY 2020). The increase in margin was driven by lower expenses. Over the last 3 years on average, earnings per share has increased by 1% per year but the company’s share price has fallen by 7% per year, which means it is significantly lagging earnings.
Reported Earnings • May 16Full year 2021 earnings released: EPS JP¥70.96 (vs JP¥53.17 in FY 2020)The company reported a decent full year result with improved earnings and profit margins, although revenues were weaker. Full year 2021 results: Revenue: JP¥25.8b (down 6.9% from FY 2020). Net income: JP¥1.06b (up 34% from FY 2020). Profit margin: 4.1% (up from 2.9% in FY 2020). The increase in margin was driven by lower expenses. Over the last 3 years on average, earnings per share has increased by 1% per year but the company’s share price has fallen by 9% per year, which means it is significantly lagging earnings.
Upcoming Dividend • Mar 23Upcoming dividend of JP¥5.00 per shareEligible shareholders must have bought the stock before 30 March 2021. Payment date: 18 June 2021. Trailing yield: 1.3%. Lower than top quartile of Japanese dividend payers (2.7%). Lower than average of industry peers (1.8%).
Is New 90 Day High Low • Feb 15New 90-day high: JP¥747The company is up 6.0% from its price of JP¥704 on 17 November 2020. The Japanese market is up 11% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 11% over the same period.
Reported Earnings • Feb 11Third quarter 2021 earnings released: EPS JP¥26.24 (vs JP¥17.89 in 3Q 2020)The company reported a decent third quarter result with improved earnings and profit margins, although revenues were weaker. Third quarter 2021 results: Revenue: JP¥6.91b (down 5.5% from 3Q 2020). Net income: JP¥393.0m (up 47% from 3Q 2020). Profit margin: 5.7% (up from 3.7% in 3Q 2020). The increase in margin was driven by lower expenses. Over the last 3 years on average, earnings per share has remained flat but the company’s share price has fallen by 8% per year, which means it is significantly lagging earnings.
Is New 90 Day High Low • Jan 08New 90-day high: JP¥723The company is up 2.0% from its price of JP¥707 on 09 October 2020. The Japanese market is up 10.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 15% over the same period.
お知らせ • Dec 04Cemedine Co., Ltd. to Report Q3, 2021 Results on Feb 09, 2021Cemedine Co., Ltd. announced that they will report Q3, 2021 results on Feb 09, 2021
お知らせ • Oct 17Cemedine Co., Ltd. to Report Q2, 2021 Results on Nov 10, 2020Cemedine Co., Ltd. announced that they will report Q2, 2021 results on Nov 10, 2020
お知らせ • Jul 17Cemedine Co., Ltd. to Report Q1, 2020 Results on Aug 07, 2020Cemedine Co., Ltd. announced that they will report Q1, 2020 results on Aug 07, 2020